Mar 2025 – Present · 1 yr 2 mos

• Appointed to lead Enterprise AI across the organization, with a mandate to drive large-scale transformational impact through AI across all functions and geographies. In this role, I am responsible for shaping and executing the enterprise-wide AI strategy—embedding AI into core operations, decision-making, and innovation to unlock business value at scale.
• I also serve as Chair of the Responsible AI Council, overseeing the governance, ethical use, and safety of AI across the company. My focus is to enable bold, responsible innovation—balancing rapid progress with safeguards aligned with GSK values

Jan 2024 – Present · 2 yrs 4 mos

• Promoted into the Commercial CDTO role as a natural evolution of my prior CDO remit, expanding my leadership to include full accountability for Data, Analytics, Commercial Technology, and Regional Digital & Tech teams across the US, EU, Greater China & Intercontinental, and Emerging Markets.

Nov 2022 – Jan 2024 · 1 yr 2 mos

• As CDO, I architected and led the creation of an integrated Customer Engagement organization—uniting technology, data, data science, AI, product management, marketing operations, and content creation under one umbrella. This transformation was centered on delivering exceptional, patient-focused customer experiences through a seamless and data-driven engagement model.
• I also actively shaped the launch of a digital-only P&L model (£2B), managing mature and tail brands entirely through technology—without traditional field force presence—setting a new benchmark for lean, digital-first commercialization.
• At the enterprise level, I continued to shape the evolution of our data platforms and intelligent ecosystems. I led the development of our Responsible AI strategy in addition to guiding my teams on delivering Gen AI Pilots and served as a key contributor to the board-level agenda on AI and Gen AI, influencing commercial priorities and future investment.

Jan 2022 – Nov 2022 · 10 mos

• In an expanded global leadership role, I evolved from leading Data, Analytics & Insights to overseeing the full spectrum of Commercial Technology platforms supporting GSK’s global markets. This included driving the development and execution of an integrated data and AI strategy across the end-to-end Pharma Commercial landscape.
• In addition to scaling a global Data & Analytics organization and shaping enterprise-wide capabilities, I provided strategic leadership across a broad Commercial Technology ecosystem—spanning sales, marketing, master data, CRM, and omnichannel platforms. I was accountable for designing scalable, future-ready architecture and solutions that enabled market agility, enterprise consistency, and AI-driven decision-making.
• My work spanned from establishing vision, capability build, architecture oversight to operational execution—delivering critical capabilities to commercial teams globally and embedding innovation through data, platforms, and advanced analytics

Sep 2019 – Mar 2022 · 2 yrs 6 mos

• Led and evolved GSK’s global Data & Analytics function into a strategic pillar of the Commercial organization, with accountability spanning global platforms, enterprise data, and AI strategy. My role expanded to oversee end-to-end Commercial Technology capabilities—supporting all global markets across sales, marketing, CRM, omnichannel, and master data platforms.
• I built and scaled a global organization from the ground up, defining the talent strategy, capability roadmap, and location footprint to support enterprise needs. I established clear build vs. source strategies to drive competitive advantage, while shaping a federated operating model and future-ready data architecture.
• Under my leadership, the team expanded its portfolio from 15 to 60+ business-critical capabilities and delivered impactful enterprise programs such as Next Best Action. I also led the transformation from traditional BI to a modern data ecosystem grounded in big data and advanced analytics, enabling smarter, faster decision-making at scale.